Can PLIA Reduce Early Post-operative Pain After PAO Surgery?

PHASE2/PHASE3RecruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

October 3, 2024

Primary Completion Date

May 31, 2026

Study Completion Date

September 30, 2026

Conditions
Hip Dysplasia
Interventions
COMBINATION_PRODUCT

Ropivacaine, Epinephrine, Ketorolac, NaCl (Saline)

"Weight 50-74.9 kg:~* ropivacaine 100mg/epinephrine 50 mcg/ketorolac 15mg in NaCl 0.9% 60mL~* 2 vials of this for 120mL total~Weight 75-99.9 kg:~* Ropivacaine 150mg/epinephrine 100 mcg/ketorolac 15mg in NaCl 0.9% 60mL~* 2 vials of this for 120mL total~Weight 100+ kg:~* Ropivacaine 200mg/epinephrine 150 mcg/ketorolac 15 mg in NaCl 0.9% 60mL~* 2 vials of this for 120mL total"

Trial Locations (1)

52242

RECRUITING

University of Iowa Health Care, Iowa City

All Listed Sponsors
collaborator

Northwestern University

OTHER

lead

Michael C Willey

OTHER